First, dual, and senior author publications have my contribution highlighted in magenta.

Second author publications in blue. Listed as group author only are noted in grey.

Zayhowski K, Roth S, Westerfield MJ, Martin MA, Blumen K, Bland HT, McQuaid SW, Mittendorf KF. Navigating sexual orientation and gender identity data privacy concerns in United States genetics practices. J Genet Couns. 2025 Apr;34(2):e70008. doi: 10.1002/jgc4.70008. PMID: 40055970.

Smith DS, Lippenszky L, LeNoue-Newton ML, Jain NM, Mittendorf KF, Micheel CM, Cella PA, Wolber J, Osterman TJ. Radiomics and Deep Learning Prediction of Immunotherapy-Induced Pneumonitis From Computed Tomography. JCO Clin Cancer Inform. 2025 Feb;9:e2400198. doi: 10.1200/CCI-24-00198. Epub 2025 Feb 20. PMID: 39977708; PMCID: PMC11867800.

Biller LH, Mittendorf K, Horiguchi M, Caruso A, Chittenden A, Ukaegbu C, Uno H, Syngal S, Yurgelun MB. Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome. JCO Precis Oncol. 2025 Jan;9:e2400691. doi: 10.1200/PO-24-00691. Epub 2025 Jan 7. PMID: 39772830; PMCID: PMC11723481 (Availaible on 2026-01-07)

Kraft SA, Mittendorf KF. Can Open Science Advance Health Justice? Genomic Research Dissemination in the Evolving Data-Sharing Landscape. Hastings Cent Rep. 2024 Dec;54 Suppl 2:S73-S83. doi: 10.1002/hast.4932. PMID: 39707953.

Mittendorf KF, Bland HT, Andujar J, Celaya-Cobbs N, Edwards C, Gerhart M, Hooker G, Hubert M, Jones SH, Marshall DR, Myers RA, Pratap S, Rosenbloom ST, Sadeghpour A, Wu RR, Orlando LA, Wiesner GL. Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer. Contemp Clin Trials.  2025 Jan;148:107714. doi: 10.1016/j.cct.2024.107714. Epub 2024 Oct 10. PMID: 39395532. 

Feigelson HS, Mittendorf KF, Okuyama S, Porter KM, Bulkley J, Shuster E, Anderson KP, Gilmore MJ, Zepp JZ, Kauffman TK, Lindberg NM, Muessig KR, Bellcross C, Ukaegbu C, Syngal S, Leo MC, Wilfond BS, On Behalf of the Cancer Health Assessments Reaching Many (CHARM) Study. Feasibility of an electronic patient-facing cancer family history tool in medically underserved populations. Genet Med Open. Vol 2, 101860. Epub 2024 Jun 25. DOI: https://doi.org/10.1016/j.gimo.2024.101860 PMID: 39669603; PMCID: PMC11613864.

Clayton EW, Bland HT, Mittendorf KF. Protecting Privacy of Pregnant and LGBTQ+ Research Participants. JAMA. 2024 Apr 15. doi: 10.1001/jama.2024.4837. Epub ahead of print. PMID: 38619831.

Lippenszky L, Mittendorf KF, Kiss Z, LeNoue-Newton ML, Napan-Molina P, Rahman P, Ye C, Laczi B, Csernai E, Jain NM, Holt ME, Maxwell CN, Ball M, Ma Y, Mitchell MB, Johnson DB, Smith DS, Park BH, Micheel CM, Fabbri D, Wolber J, Osterman TJ. Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO Clinical Cancer Informatics. 2024 Feb;8:e2300207. doi: 10.1200/CCI.23.00207. PMID: 38427922; PMCID: PMC10919473. 

Gilmore MJ, Knerr S, Kraft SA, Bulkley JE, Biesecker BB, Feigelson HS, Hunter JE, Jenkins CL, Kauffman TL, Lee SS, Liles EG, Mittendorf KF, Muessig KR, Porter KM, Rolf BA, Rope AF, Zepp JM, Anderson KP, Devine B, Joseph G, Leo MC, Goddard K, Wilfond BS. Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study. Public Health Genomics. 2024;27(1):16-22. doi: 10.1159/000535610. Epub 2023 Dec 23. PMID: 38142673.

Groom HC, Brooks NB, Weintraub ES, Slaughter MT, Mittendorf KF, Naleway AL. Incidence of Adolescent Syncope and Related Injuries Following Vaccination and Routine Venipuncture.  Journal of Adolescent Health. 2024 Apr;74(4):696-702. doi: 10.1016/j.jadohealth.2023.11.005. Epub 2023 Dec 9. PMID: 38069938; PMCID: PMC10960660. Featured in issue editorial.

Casillan A, Florido ME, Galarza-Cornejo J, Bakken S, Lynch JA, Chung WK, Mittendorf KF, Berner ES, Connolly JJ, Weng C, Holm IA, Khan A, Kiryluk K, Limdi NA, Petukhova L, Sabatello M, Wynn J. Participant-guided development of bilingual genomic educational infographics for Electronic Medical Records and Genomics Phase IV study. J Am Med Inform Assoc. 2024 Jan 18;31(2):306-316. doi: 10.1093/jamia/ocad207. PMID: 37860921; PMCID: PMC10797276.

Kauffman TL, Irving SA, Brooks N, Vesco KK, Slaughter M, Smith N, Tepper NK, Olson CK, Weintraub ES, Naleway AL; Vaccine Safety Datalink Menstrual Irregularities Workgroup. Postmenopausal bleeding after COVID-19 vaccination. Am J Obstet Gynecol. 2024 Jan;230(1):71.e1-71.e14. doi: 10.1016/j.ajog.2023.09.007. Epub 2023 Sep 17. PMID: 37726057. [Workgroup Contributor]

Bland HT, Gilmore MJ, Andujar J, Martin MA, Celaya-Cobbs N, Edwards C, Gerhart M, Hooker GW, Kraft SA, Marshall DR, Orlando LA, Paul NA, Pratap S, Rosenbloom ST, Wiesner GL, Mittendorf KF. Conducting inclusive research in genetics for transgender, gender-diverse, and sex-diverse individuals: Case analyses and recommendations from a clinical genomics study. J Genet Couns. 2023 Sep 4. doi: 10.1002/jgc4.1785. Epub ahead of print. PMID: 37667436. PMCID: PMC10909936

Guo B, Knerr S, Kauffman TL, Mittendorf KF, Keast E, Gilmore MJ, Feigelson HS, Lynch FL, Muessig KR, Okuyama S, Zepp JM, Veenstra DL, Hsu L, Phipps AI, Lindström S, Leo MC, Goddard KAB, Wilfond BS, Devine B; CHARM Study team. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. Cancer Med. 2023 Sep;12(18):19112-19125. doi: 10.1002/cam4.6485. Epub 2023 Aug 30. PMID: 37644850; PMCID: PMC10557878.

Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Research and Treatment. 2023 Jul 20. doi: 10.1007/s10549-023-07007-w. Epub ahead of print. PMID: 37470892.

Mittendorf KF. Reimagining Access: Critical Examination of Barriers to Full STEM Workforce Participation for Disabled Individuals. National Academies of Science, Engineering and Medicine Commissioned Paper for the Disrupting Ableism and Advancing STEM: Promoting the Success of People with Disabilities in the STEM Workforce workshop series. Washington, DC. June 16, 2023. Available from: https://nap.nationalacademies.org/resource/27245/Mittendorf_Reimagining_Access_Barriers_to_STEM_Workforce_for_Disabled_Individuals.pdf 

See also: National Academies of Sciences, Engineering, and Medicine. 2024. Disrupting Ableism and Advancing STEM: Promoting the Success of People with Disabilities in the STEM Workforce: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. https://doi.org/10.17226/27245.

Hunter JE, Riddle L, Joseph G, Amendola LM, Gilmore MJ, Zepp JM, Shuster E, Bulkley JE, Muessig KR, Anderson KP, Goddard KAB, Wilfond BS, Leo MC; CHARM study team. Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. Genet Med. 2023 Nov;25(11):100923. doi: 10.1016/j.gim.2023.100923. Epub 2023 Jul 5. PMID: 37421176; PMCID: PMC10766857. [CHARM Study Team Contributor]

Naleway AL, Henninger ML, Irving SA, Bianca Salas S, Kauffman TL, Crane B, Mittendorf KF, Harsh S, Elder C, Gee J. Epidemiology of Upper Limb Complex Regional Pain Syndrome in a Retrospective Cohort of Persons Aged 9-30 Years, 2002-2017. The Permanente Journal. 2023 May 8:1-12. doi: 10.7812/TPP/22.170. Epub ahead of print. PMID: 37154719.

Okuyama S, White LL, Anderson KP, Medina E, Deutsch S, Ransom C, Jackson P, Kauffman TL, Mittendorf KF, Leo MC, Bulkley JE, Wilfond BS, Goddard KA, Feigelson HS. Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project. J Community Genet. 2023 May 1. doi: 10.1007/s12687-023-00647-x. Epub ahead of print. PMID: 37126135.

Rahman P, Ye C, Mittendorf KF, Lenoue-Newton M, Micheel C, Wolber J, Osterman T, Fabbri D. Accelerated curation of checkpoint inhibitor-induced colitis cases from electronic health records. JAMIA Open. 2023 Apr 1;6(1):ooad017. doi: 10.1093/jamiaopen/ooad017. PMID: 37012912; PMCID: PMC10066800.

Linder JE, Allworth A, Bland ST, Caraballo PJ, Chisholm RL, Clayton EW, Crosslin DR, Dikilitas O, DiVietro A, Esplin ED, Forman S, Freimuth RR, Gordon AS, Green R, Harden MV, Holm IA, Jarvik GP, Karlson EW, Labrecque S, Lennon NJ, Limdi NA, Mittendorf KF, et al. Returning integrated genomic risk and clinical recommendations: The eMERGE study. Genetics in Medicine. 2023 Apr;25(4):100006. doi: 10.1016/j.gim.2023.100006. Epub 2023 Jan 6. PMID: 36621880; PMCID: PMC10085845.

Song J, Forrest N, Gordon A, Kottyan L, Mittendorf KF, Wei WQ, Ramsey-Goldman R, Walunas T, Kho A. Utilization of electronic health record data to evaluate the association of urban environment on systemic lupus erythematosus symptoms. Rheumatology (Oxford). 2022 Nov 16:keac647. doi: 10.1093/rheumatology/keac647. Epub ahead of print. PMID: 36383166.

Van Egeren D, Kohli K, Warner JL, Bedard PL, Riely G, Lepisto E, Schrag D, LeNoue-Newton M, Catalano P, Kehl KL, Michor F; AACR Project GENIE Consortium represented by Shawn Sweeney. Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis. Scientific Reports. 2022 Nov 9;12(1):19055. doi: 10.1038/s41598-022-21448-1. PMID: 36351964; PMCID: PMC9646734. [Consortium Contributor]

Lindberg NM, Mittendorf KF, Duenas DM, Anderson K, Koomas A, Kraft SA, Okuyama S, Shipman KJ, Vandermeer ML, Goddard KA, Wilfond BS, McMullen C. Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. The Permanente Journal. 2022 Jun 29;26(2):28-39. doi: 10.7812/TPP/21.091. Epub 2022 Jun 17. PMID: 35933674.

Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, Savich R, Slavotinek A, Smith HS, Gelb BD, Veenstra DL. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genetics in Medicine. 2022 Jul 13:S1098-3600(22)00813-9. doi: 10.1016/j.gim.2022.06.004. Epub ahead of print. PMID: 35833928.

Muenzen KD, Amendola LM, Kauffman TL, Mittendorf KF, Bensen JT, Chen F, Green R, Powell BC, Kvale M, Angelo F, Farnan L, Fullerton SM, Robinson JO, Li T, Murali P, Lawlor JMJ, Ou J, Hindorff LA, Jarvik GP, Crosslin DR. Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience. Human Genetics and Genomics Advances. 2022 May 20;3(3):100120. doi: 10.1016/j.xhgg.2022.100120. PMID: 35707062; PMCID: PMC9190054.

Mittendorf KF, Lewis HS, Duenas DM, Eubanks DJ, Gilmore MJ, Goddard KAB, Joseph G, Kauffman TL, Kraft SA, Lindberg NM, Reyes AA, Shuster E, Syngal S, Ukaegbu C, Zepp JM, Wilfond BS, Porter KM. Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. Hereditary Cancer in Clinical Practice. 2022 Jun 10;20(1):22. doi: 10.1186/s13053-022-00231-3. PMID: 35689290; PMCID: PMC9188215.

Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B. Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. Cancer. 2022 Jun 9. doi: 10.1002/cncr.34349. [Epub ahead of print]. PMID: 35679147.

Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP. Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genetics in Medicine. 2022 Mar 16;. doi: 10.1016/j.gim.2022.02.006. [Epub ahead of print] PubMed PMID: 35305866.

O'Daniel JM, Ackerman S, Desrosiers LR, Rego S, Knight SJ, Mollison L, Byfield G, Anderson KP, Danila MI, Horowitz CR, Joseph G, Lamoure G, Lindberg NM, McMullen CK, Mittendorf KF, Ramos MA, Robinson M, Sillari C, Madden EB. Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium. Genetics in Medicine. 2022 Feb 25;. doi: 10.1016/j.gim.2022.01.008. [Epub ahead of print] PubMed PMID: 35227608.

Rolf BA, Schneider JL, Amendola LM, Davis JV, Mittendorf KF, Schmidt MA, Jarvik GP, Wilfond BS, Goddard KAB, Ezzell Hunter J. Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment. Journal of Genetic Counseling. 2022 Feb;31(1):230-241. doi: 10.1002/jgc4.1476. Epub 2021 Jul 23. PubMed PMID: 34302314; PubMed Central PMCID: PMC8783924.

Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precision Oncology. 2021;5. doi: 10.1200/PO.21.00233. eCollection 2021. Review. PubMed PMID: 34778694; PubMed Central PMCID: PMC8585306.

Lindberg NM, Gutierrez AM, Mittendorf KF, Ramos MA, Anguiano B, Angelo F, Joseph G. Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned. Personalized Medicine. 2021 Sep;18(5):441-454. doi: 10.2217/pme-2020-0075. Epub 2021 Aug 27. PubMed PMID: 34448595; PubMed Central PMCID: PMC8438935.

Holt ME, Mittendorf KF, LeNoue-Newton M, Jain NM, Anderson I, Lovly CM, Osterman T, Micheel C, Levy M. My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase. JCO Clinical Cancer Informatics. 2021 Sep;5:995-1004. doi: 10.1200/CCI.21.00084. PubMed PMID: 34554823; PubMed Central PMCID: PMC8807017.

Mittendorf KF*, Kauffman TL*, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB. Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. Contemporary Clinical Trials. 2021 Jul;106:106432. doi: 10.1016/j.cct.2021.106432. Epub 2021 May 11. PubMed PMID: 33984519; PubMed Central PMCID: PMC8336568. Corrigendum in doi: 10.1016/j.cct.2022.106682

Mittendorf KF*, Ukaegbu C*, Gilmore MJ, Lindberg NM, Kauffman TL, Eubanks DJ, Shuster E, Allen J, McMullen C, Feigelson HS, Anderson KP, Leo MC, Hunter JE, Sasaki SO, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM 5™) for lynch syndrome risk assessment in a diverse population. Familial Cancer. 2021 Mar 23. Online ahead of print. doi: 10.1007/s10689-021-00243-3. PubMed PMID: 33754278; PubMed Central PMCID: PMC8458476.

Kraft SA, Porter KM, Duenas DM, Guerra C, Joseph G, Lee SS, Shipman KJ, Allen J, Eubanks D, Kauffman TL, Lindberg NM, Anderson K, Zepp JM, Gilmore MJ, Mittendorf KF, Shuster E, Muessig KR, Arnold B, Goddard KAB, Wilfond BS. Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study. AJOB Empirical Bioethics. 2021. 12, 1-11. PubMed PMID: 32981477; PubMed Central PMCID: PMC7785634.

Hutchison JM, Shi KC, Scheidt HA, Fantin SM, Parson KF, Pantelopulos GA, Harrington HR, Mittendorf KF, Qian S, Stein RA, Collier SE, Chambers MG, Katsaras J, Voehler MW, Ruotolo BT, Huster D, McFeeters RL, Straub JE, Nieh MP, Sanders CR. Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane Proteins. Journal of the American Chemical Society. 2020. 142, 12715-12729. PubMed PMID: 32575981; PubMed Central PMCID: PMC7924963.

Jain N, Mittendorf KF, Holt M, Lenoue-Newton M, Maurer I, Miller C. Stachowiak M, Botyrius M, Cole J, Micheel C, The My Cancer Genome clinical trial data model and trial curation workflow. Journal of the American Medical Informatics Association. 2020. 27, 1057-1066. PubMed PMID: 32483629; PubMed Central PMCID: PMC7647323.

Mittendorf KF, Hunter JE, Schneider JL, Shuster E, Rope AF, Zepp J, Gilmore MJ, Muessig KR, Davis JV, Kauffman TL, Bergen KM, Wiesner GL, Acheson LS, Peterson SK, Syngal S, Reiss JA, Goddard KAB. Recommended Care and Care Adherence Following a Diagnosis of Lynch Syndrome: A mixed-methods study. Hereditary Cancer in Clinical Practice. 2019. 17 (31). PubMed PMID: 31890059; PubMed Central PMCID: PMC6915941.

Paquin RS, Mittendorf KF, Lewis MA, Hunter JE, Lee K, Berg JS, Williams MS, Goddard KAB. Expert and Lay Perspectives on Burden, Risk, Tolerability, and Acceptability of Clinical Interventions for Genetic Disorders. Genetics in Medicine. 2019 Nov. 21(11):2561-2568. PubMed PMID: 31028355; PubMed Central PMCID: PMC6815237.

Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld, Lee K, Lindor NM, Martin CL, Milosavljevic, Mittendorf KF, Muessig KR, O’Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Lygia N, Sobriera M, Weaver MA, Williams MS, Evans JP, Goddard KAB on behalf of the ClinGen Resource. Evidence‐based Assessments of Clinical Actionability in the Context of Secondary Findings: Updates from ClinGen's Actionability Working Group. Human Mutation. 2018. 39, 1677-1685. PubMed PMID: 30311382; PubMed Central PMCID: PMC6211797.

Naleway A, Mittendorf KF, Irving S, Henninger M, Crane B, Smith N, Daley M, Gee J. Primary Ovarian Insufficiency and Adolescent Vaccination. Pediatrics. 2018. 142, e20180943. PubMed PMID: 30131438; PubMed Central PMCID: PMC6719304.

Levy MA, Micheel C, Jain N, Mittendorf K. Assessment of Actionability of Cancer Genomic Testing Panels Based on a Structured Clinical Trial Knowledge Base. Journal of Clinical Oncology. May 20, 2017. 35, no. 15_suppl 6533-6533. [abstract]

Levy MA, Osterman T, Jain N, Mittendorf K, Micheel C. Utility of Adding Clinical Data to a Molecular Results Portal for improving clinical trial prescreening efficiency. Journal of Clinical Oncology. May 30, 2017. 35, no. 15_suppl. [abstract]

Mittendorf KF*, Marinko JT*, Hampton CM, Ke Z, Hadziselimovic A, Schlebach JP, Law CL, Li J, Wright ER, Sanders CR, Ohi MD. Peripheral Myelin Protein 22 Alters Membrane Architecture. Science Advances. 2017. 3, e1700220. PubMed PMID: 28695207; PubMed Central PMCID: PMC5498104.

Takizawa Y, Binshtein E, Erwin AL, Pyburn TM, Mittendorf KF, and Ohi MD. While the Revolution Will Not Be Crystalized, Biochemistry Reigns Supreme. Protein Science, 2017. 26, 69-81. PubMed PMID: 27673321; PubMed Central PMCID: PMC5192976.

Schlebach JP, Narayan M, Alford C, Mittendorf KF, Carter BD, Li J, Sanders CR. Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22. Journal of the American Chemical Society, 2015. 137, 8758-8768. PubMed PMID: 26102530; PubMed Central PMCID: PMC4507940.

Mittendorf KF*, Kroncke BM*, Meiler J, Sanders CS. Homology Model of PMP22 Suggests Most Mutations Resulting in Severe Peripheral Neuropathy Disrupt Packing of Transmembrane Helices. Biochemistry, 2014. 48, 1-34. PubMed PMID: 25243937; PubMed Central PMCID: PMC4188248. Highlighted on Biochemistry Homepage.

Song Y*, Mittendorf KF*, Lu Z, Sanders CR. Impact of Bilayer Lipid composition on the Structure and Topology of the Transmembrane Amyloid Precursor C99 Protein. Journal of the American Chemical Society, 2014. 136, 4093-4096.  PubMed PMID: 24564538; PubMed Central PMCID: PMC3985881.

Schlebach JP, Peng D, Kroncke BM, Mittendorf KF, Marayan M, Carter BD, Sanders CR. Reversible Folding of Human Peripheral Myelin Protein 22, a Tetraspan Membrane Protein. Biochemistry 2013. 52, 3229-3241. PubMed PMID: 23639031; PubMed Central PMCID: PMC3762913.

Mittendorf KF, Deatherage CL, Ohi MD, Sanders CR. Tailoring of Membrane Proteins by Alternative Splicing of Pre-mRNA. Biochemistry, 2012. 51, 5541-5556. PubMed PMID: 22708632; PubMed Central PMCID: PMC3448030.

Sanders CR and Mittendorf KF. Tolerance to Changes in Membrane Lipid Composition as a Selected Trait of Membrane Proteins. Biochemistry, 2011. 50, 7858-7867. PubMed PMID: 21848311; PubMed Central PMCID: PMC3172382. Cover Image.

*Authors contributed equally

Contributions to NASEM Workshop Highlighted and Quoted in: National Academies of Sciences, Engineering, and Medicine. 2024. Disrupting Ableism and Advancing STEM: Promoting the Success of People with Disabilities in the STEM Workforce: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. https://doi.org/10.17226/27245 

Contributions to NASEM Workshop Highlighted and Quoted in: National Academies of Sciences, Engineering, and Medicine. 2024. Sustaining Community Engagement in Genomics Research: Proceedings of a Workshop—in Brief. Washington, DC: The National Academies Press. https://doi.org/10.17226/28044 

Mittendorf, KF. NPA Accessibility & Inclusion Equity Summit. National Postdoctoral Association. Invited Panelist. November 15, 2024. Agenda available from: https://www.nationalpostdoc.org/page/2024AIES  

Mittendorf KF. Training on Accessible Science Communication and Visual Scientific Representation in Presentations. Centers for Early Detection and Interception, Dana-Farber Cancer Institute. Sept 18, 2024.

Mittendorf KF. Session II. Challenges and Opportunities for Sustaining Community Engagement and Partnerships in Genomics Research: Pacing for Partnership. National Academies of Science, Engineering and Medicine (NASEM). Sustaining Community Engagement in Genomics Research: A Workshop. July 17, 2024. Available from: https://www.nationalacademies.org/event/42785_07-2024_sustaining-community-engagement-in-genomics-research-a-workshop  

Disrupting Ableism and Advancing STEM: A Year of Reflections and Actions. Panelist. National Academies of Science, Engineering and Medicine (NASEM).  June 10, 2024. Available from: https://www.nationalacademies.org/event/42511_06-2024_disrupting-ableism-and-advancing-stem-a-year-of-reflections-and-actions   

Duerstock B, Hubert K, Mittendorf KF. Creating and Maintaining Accessible Research Environments. Panel Presentation. Accessibility in STEM (AiS) Worskhop Series. Genetics Society of America. July 13, 2023. Available from: https://youtu.be/2hPw8NYbgb0   

Mittendorf KF. Understanding Workplace and Workforce Barriers to Full Participation of People with Disabilities: Reimagining Access. National Academies of Science, Engineering and Medicine (NASEM). Disrupting Ableism and Advancing STEM. June 16, 2023. Available from: https://www.nationalacademies.org/event/06-16-2023/disrupting-ableism-and-advancing-stem-rooting-out-bias-and-barriers  

Bland HT and Mittendorf KF. Sex and gender in genetics research: Are we inclusive? eMERGE Steering Committee Scientific Presentation. eMERGE SC Meeting. February 1, 2023

Liu C, Mittendorf KF, Thayer J, Cimino J, Freimuth R. Hidden socio-technical gaps in centralized data solutions for a multisite research network: experiences from the eMERGE IV project. Panel Presentation. AMIA Informatics Summit. March 14, 2023

Mittendorf KF.  Scientist-Artists: Embracing Duality. Moderated Panel Presentation and Discussion. Lab-to-Table Conversations. Vanderbilt University School of Medicine Basic Sciences. Dean’s Lecture. July 27, 2022. Available at: https://www.youtube.com/watch?v=9dA0f3Wc9jQ&feature=youtu.be  

Mittendorf KF, Micheel C, Park BH, Piazza B. Disability Accommodations in the Workplace: A Model for Success. Moderated Panel Presentation and Discussion. Disability Employee Resource Group ADA Celebration Outreach Presentation. Vanderbilt University Medical Center. July 18, 2022.

Mittendorf KF. Equitable Family History Risk Assessment for Hereditary Cancer Syndromes in a Primary Care Population. First Annual Cancer Health Equity Retreat. Vanderbilt-Ingram Cancer Center. July 8, 2022

Mittendorf KF.  Cancer Health Assessments Reaching Many: A protocol to increase access to hereditary cancer syndrome diagnosis. Moving Cancer Moonshot Forward by Connecting More States, Health Systems, Sectors and Communities to Improve Health Equity, Access and Outcomes. Self Made Health Network. June 14, 2022. Available from: https://event.on24.com/wcc/r/3737582/724687F099E815A18388CF5E794BDB6B 

Mittendorf KF. There and Back Again. Guest Lecture and Discussion. Genome Sciences Association for the Inclusion of Minority Students. University of Washington. November 2, 2020.

Mittendorf KF. Do patients receive recommended care in Lynch syndrome? Junior investigator presentation. CSER Consortium Meeting. May 10, 2019.

Mittendorf KF. Do expert opinions on the nature of intervention reflect the opinions of the general population? ClinGen Consortium Call. June 15, 2018

Mittendorf KF. Keynote Address. Academic Awards Convocation. DePauw University. April 24, 2017.

Mittendorf KF. Impact of Bilayer Lipid Composition on the Structure and Topology of the Amyloid Precursor Protein Fragment, C99. Guest Lecture. Fisk University, Nashville, TN. March 16, 2015. 

Mittendorf KF. Pigs in a Blanket on My Rafting Trip: Membrane Proteins and Neurodegeneration. The Karpay Award in Structural Biology: Molecular Biophysics Training Program Seminar Series. Vanderbilt University, Nashville, TN. January 20, 2015.

Mittendorf KF. What is Graduate School? HONR 193: Understanding Science: Science Research Fellows First Year Seminar. Guest Lecture and Discussion. DePauw University. September 5, 2014.

Mittendorf KF. Q & A Session with Goldwater and NSF GRFP Applicants. Guest Lecture and Discussion. DePauw University. September 5, 2014.

Mittendorf KF. How to Prepare for Life in Graduate School. HONR 491: Science Research Fellows Senior Seminar. DePauw University. September 3, 2014.

Mittendorf KF. Folding and Misfolding of Peripheral Myelin Protein 22. Telluride Science Research Center Workshop: Membrane Protein Folding and Functioning. Telluride, CO. August 7, 2013.

Mittendorf KF, Micheel C, LeNoue-Newton M, Rahman P, Fabbri F, Wolber J, Osterman TJ, Fouda M, Park BH. Overcoming barriers in academic-industry partnerships to improve predictive modeling in immuno-oncology. Journal of Clinical Oncology. 2022 40:16_suppl, e13581-e13581. [abstract]

Horváth G, Kiss Z, Csernai E, Lippenszky L, Napan-Molina P, LeNoue-Newton M, Mittendorf K, Smith D, Park BH, Wolber J, Osterman TJ. Predicting immune checkpoint inhibitor-related hepatitis using electronic health records of patients. Journal of Clinical Oncology. 2022 40:16_suppl, e13564-e13564. [abstract]

Csernai E, Horváth G, LeNoue-Newton M, Mittendorf K, Smith D, Park BH, Wolber J, Osterman TJ. Rolling window-based hepatitis toxicity prediction from routine bloodwork in patients undergoing immune checkpoint inhibitor therapy. Journal of Clinical Oncology. 2022 40:16_suppl, e13565-e13565. [abstract]

Levy MA, Osterman T, Jain N, Mittendorf K, Micheel C. Utility of Adding Clinical Data to a Molecular Results Portal for improving clinical trial prescreening efficiency. Journal of Clinical Oncology. May 30, 2017. 35, no. 15_suppl. [abstract]

Levy MA, Micheel C, Jain N, Mittendorf K. Assessment of Actionability of Cancer Genomic Testing Panels Based on a Structured Clinical Trial Knowledge Base. Journal of Clinical Oncology. May 20, 2017. 35, no. 15_suppl 6533-6533. [abstract]